Sentinel lymph node biopsy in breast cancer: The node to recovery

被引：0

作者：

Goyal A. ^{[1
]}

机构：

[1] Department of Surgery School of Medicine, Cardiff University

来源：

Indian Journal of Surgical Oncology | 2010年 / 1卷 / 1期

关键词：

Blue dye; Breast cancer; Radioisotope; Sentinel lymph node biopsy;

D O I：

10.1007/s13193-010-0005-y

中图分类号：

学科分类号：

摘要：

The widespread adoption of sentinel lymph node biopsy to stage the axilla has led to decrease in arm and shoulder morbidity. Sentinel lymph node biopsy is suitable for patients with clinically/radiologically node negative invasive breast cancer and selected patients with DCIS (those with clinical/radiological mass or extensive lesions requiring mastectomy). The combined isotope-blue dye injection technique gives the best results. We inject the isotope intra-dermally preoperatively and blue dye dye subdermally after anesthetic induction into the tumour quadrant peri-areolar tissue. Lymphoscintiscan is not necessary but is useful during the learning phase. Sentinel node biopsy can be performed through a small transverse or vertical axillary incision (~3 cm) appropriately placed to allow axillary lymph node clearance if needed. © 2010 Indian Association of Surgical Oncology.

引用

页码：10 / 13

页数：3

共 23 条

[1]

Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T., Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe, Surg Oncol, 2, pp. 335-339, (1993)

[2]

Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L., Lymphatic mapping and sentinel lymphadenectomy for breast cancer, Ann. Surg., 220, pp. 391-398, (1994)

[3]

Albertini J.J., Et al., Lymphatic mapping and sentinel node biopsy in the patient with breast cancer, Jama, 276, pp. 1818-1822, (1996)

[4]

Gill G., Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial, Ann Surg Oncol, 16, pp. 266-275, (2009)

[5]

Krag D.N., Et al., Technical outcomes of sentinel-lymph-node resection and conventional axillarylymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, pp. 881-888, (2007)

[6]

Mansel R.E., Et al., Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial, J Natl Cancer Inst, 98, pp. 599-609, (2006)

[7]

Purushotham A.D., Et al., Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial, J Clin Oncol, 23, pp. 4312-4321, (2005)

[8]

Veronesi U., Et al., A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, pp. 546-553, (2003)

[9]

Zavagno G., Et al., A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial, Ann Surg, 247, pp. 207-213, (2008)

[10]

Goyal A., Et al., Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases, Breast Cancer Res Treat, 98, pp. 311-314, (2006)

← 1 2 3 →